MetaVia Inc. (MTVA)
CIK 1638287 · all EDGAR filings →
Same rating bands the category standard uses, but free, with the formula on the chip and the gaps in the data said out loud.
Shares outstanding over time
Latest: 6.6M shares as of Aug 3, 2026 (10-Q). Share count fell from 38.8M to 4.9M between Nov 9, 2023 and Mar 25, 2024, a pattern consistent with a reverse split (roughly 1-for-8); simultaneous issuance can skew the raw ratio, so confirm in the filings. The red bar marks the cliff.
Cash runway
~10 months of cash left
burning $3.9M / quarter
Full breakdown: cash runway tool · source filing →
Warrants
| Tranche | Warrants | Exercise price | Term | Notes |
|---|---|---|---|---|
| January2026 Series C Warrant Exercise Price3.1000 | 4.5M | $3.1 | — | — |
| January2026 Series D Warrant Exercise Price3.1000 | 3.8M | $3.1 | — | — |
| June2024 Series B Warrant Exercise Price43.23 | 693,962 | $43.23 | — | — |
| November2022 Series B Warrant Exercise Price0.00 | 16,176 | $264 | — | — |
| June2024 Placement Agent Warrant Exercise Price54.0375 | 11,564 | $54.0375 | — | — |
| Warrants Exercise Price15919.20 | 942 | $15919.2 | — | — |
| Series C Warrant | 1.5 | $3.1 | — | — |
| Series D Warrant | 1.5 | $3.1 | — | — |
| Pre Funded Warrants | 1 | $0.001 | — | — |
Tranches exactly as the company dimensioned them in its 10-Q filed Aug 6, 2026 →. Groupings can overlap (a “Series E and F” row is not additive with a “Series E” row), so do not sum this column. A tranche the filer did not tag is absent here, not absent from the cap table. DOWN-ROUND = the filer tagged price-protection accounting scoped to that tranche.
Warrants outstanding: 9.0M underlying shares, as reported Jun 30, 2026 (10-Q).
Reported exercise price: $312020 (aggregate figure as tagged; individual tranches vary).
Balance-sheet fair value of warrants: $24.3M as of Dec 31, 2022.
Rough fully diluted estimate: 15.5M = 6.6M O/S + 9.0M warrant shares. An estimate, not a filing figure: it ignores converts, options and RSUs, and the two inputs carry different as-of dates.
Convertible notes
No convertible-note facts tagged in the 10-Q filed Aug 6, 2026. If convertible notes exist, their terms live in exhibit prose for this filer and are not parsed; absence of a tag is not proof of absence. The exhibits are the ground truth.
Fully diluted build-up
Shares outstanding plus every potential-share instrument the filer tagged in XBRL, each at its own as-of date. An estimate assembled from filed figures, not a filing figure itself.
| Shares outstanding | 6.6M | Aug 3, 2026 |
| + January2026 Series C Warrant Exercise Price3.1000 (if exercised) | 4.5M | Jun 30, 2026 |
| + January2026 Series D Warrant Exercise Price3.1000 (if exercised) | 3.8M | Jun 30, 2026 |
| + June2024 Series B Warrant Exercise Price43.23 (if exercised) | 693,962 | Jun 30, 2026 |
| + November2022 Series B Warrant Exercise Price0.00 (if exercised) | 16,176 | Jun 30, 2026 |
| + June2024 Placement Agent Warrant Exercise Price54.0375 (if exercised) | 11,564 | Jun 30, 2026 |
| + Warrants Exercise Price15919.20 (if exercised) | 942 | Jun 30, 2026 |
| + Series C Warrant (if exercised) | 1.5 | Jan 31, 2026 |
| + Series D Warrant (if exercised) | 1.5 | Jan 31, 2026 |
| + Pre Funded Warrants (if exercised) | 1 | Jan 31, 2026 |
| Fully diluted estimate | 15.5M | +136.0% vs O/S |
Still excluded, because the filer does not tag them in countable form: employee options and RSUs, any instrument living only in exhibit prose, and instruments above missing a share count. Inputs carry different as-of dates, shown per row. Each figure traces to the tranche and note tables above and their cited filings.
Registrations and offerings
Registered offering capacity on live registrations: $34.5Mfrom the structured fee exhibits; registered is not remaining, takedowns are not subtracted
Last 12 months: 3 executed · 3 registered.
Full history and shelf status: offering checker · S-3 shelf checker
Source: SEC EDGAR XBRL company facts and filing metadata, fetched live and cached briefly. Share counts are cover-page figures with their form named. Warrant tranches and convertible notes come from the dimensioned facts in the latest 10-Q/10-K instance document, exactly as the company tagged them; untagged tranches and notes are absent, not disproven. Nothing on this page is manually verified and nothing is behind a login: what free data supports is shown, what it cannot support is stated. Not investment advice.
Keep going: float checker · offering calendar · short-squeeze screener · full MTVA workspace